Skip to content

Replimune Group REPL Accumulated Depreciation

Accumulated Depreciation at other companies

Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$11.66M+21.8%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$10.94M+21.8%
Amgen logo
AmgenAMGN
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Incyte logo
IncyteINCY
Moderna logo
ModernaMRNA

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's accumulated depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's accumulated depreciation?
Replimune Group (REPL) reported accumulated depreciation of $15.96M in Q4 2025.
How has Replimune Group's accumulated depreciation changed year-over-year?
Replimune Group's accumulated depreciation increased by 27.2% year-over-year, from $12.55M to $15.96M.
What is the long-term trend for Replimune Group's accumulated depreciation?
Over 4 years (2021 to 2025), Replimune Group's accumulated depreciation has grown at a 50.0% compound annual growth rate (CAGR), from $2.65M to $13.4M.
What does accumulated depreciation mean?
Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.